China · Delayed Price · Currency is CNY Verve Therapeutics Statistics
Total Valuation
SHA:600131 has a market cap or net worth of CNY 21.55 billion. The enterprise value is 19.32 billion.
| Market Cap | 21.55B |
| Enterprise Value | 19.32B |
Important Dates
The next estimated earnings date is Thursday, August 28, 2025.
| Earnings Date | Aug 28, 2025 |
| Ex-Dividend Date | Jul 29, 2025 |
Share Statistics
SHA:600131 has 1.20 billion shares outstanding. The number of shares has increased by 1.73% in one year.
| Current Share Class | 1.20B |
| Shares Outstanding | 1.20B |
| Shares Change (YoY) | +1.73% |
| Shares Change (QoQ) | +8.26% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 10.58% |
| Float | 424.06M |
Valuation Ratios
The trailing PE ratio is 31.54 and the forward PE ratio is 23.32.
| PE Ratio | 31.54 |
| Forward PE | 23.32 |
| PS Ratio | 2.91 |
| PB Ratio | 3.16 |
| P/TBV Ratio | 3.67 |
| P/FCF Ratio | 139.09 |
| P/OCF Ratio | 41.10 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 22.22, with an EV/FCF ratio of 124.71.
| EV / Earnings | 27.73 |
| EV / Sales | 2.61 |
| EV / EBITDA | 22.22 |
| EV / EBIT | 32.95 |
| EV / FCF | 124.71 |
Financial Position
The company has a current ratio of 1.81, with a Debt / Equity ratio of 0.05.
| Current Ratio | 1.81 |
| Quick Ratio | 1.59 |
| Debt / Equity | 0.05 |
| Debt / EBITDA | 0.43 |
| Debt / FCF | 2.38 |
| Interest Coverage | 46.81 |
Financial Efficiency
Return on equity (ROE) is 10.58% and return on invested capital (ROIC) is 5.21%.
| Return on Equity (ROE) | 10.58% |
| Return on Assets (ROA) | 2.87% |
| Return on Invested Capital (ROIC) | 5.21% |
| Return on Capital Employed (ROCE) | 8.28% |
| Revenue Per Employee | 5.86M |
| Profits Per Employee | 551,153 |
| Employee Count | 1,264 |
| Asset Turnover | 0.59 |
| Inventory Turnover | 11.43 |
Taxes
In the past 12 months, SHA:600131 has paid 24.56 million in taxes.
| Income Tax | 24.56M |
| Effective Tax Rate | 3.41% |
Stock Price Statistics
The stock price has increased by +7.63% in the last 52 weeks. The beta is 0.52, so SHA:600131's price volatility has been lower than the market average.
| Beta (5Y) | 0.52 |
| 52-Week Price Change | +7.63% |
| 50-Day Moving Average | 17.84 |
| 200-Day Moving Average | 19.14 |
| Relative Strength Index (RSI) | 51.29 |
| Average Volume (20 Days) | 8,850,103 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:600131 had revenue of CNY 7.41 billion and earned 696.66 million in profits. Earnings per share was 0.57.
| Revenue | 7.41B |
| Gross Profit | 1.52B |
| Operating Income | 581.55M |
| Pretax Income | 720.69M |
| Net Income | 696.66M |
| EBITDA | 803.48M |
| EBIT | 581.55M |
| Earnings Per Share (EPS) | 0.57 |
Balance Sheet
The company has 2.60 billion in cash and 367.97 million in debt, giving a net cash position of 2.23 billion or 1.86 per share.
| Cash & Cash Equivalents | 2.60B |
| Total Debt | 367.97M |
| Net Cash | 2.23B |
| Net Cash Per Share | 1.86 |
| Equity (Book Value) | 6.81B |
| Book Value Per Share | 5.67 |
| Working Capital | 4.24B |
Cash Flow
In the last 12 months, operating cash flow was 524.28 million and capital expenditures -369.37 million, giving a free cash flow of 154.91 million.
| Operating Cash Flow | 524.28M |
| Capital Expenditures | -369.37M |
| Free Cash Flow | 154.91M |
| FCF Per Share | 0.13 |
Margins
Gross margin is 20.47%, with operating and profit margins of 7.85% and 9.40%.
| Gross Margin | 20.47% |
| Operating Margin | 7.85% |
| Pretax Margin | 9.73% |
| Profit Margin | 9.40% |
| EBITDA Margin | 10.85% |
| EBIT Margin | 7.85% |
| FCF Margin | 2.09% |
Dividends & Yields
This stock pays an annual dividend of 0.17, which amounts to a dividend yield of 0.95%.
| Dividend Per Share | 0.17 |
| Dividend Yield | 0.95% |
| Dividend Growth (YoY) | -17.30% |
| Years of Dividend Growth | 5 |
| Payout Ratio | 36.39% |
| Buyback Yield | -1.73% |
| Shareholder Yield | -0.78% |
| Earnings Yield | 3.23% |
| FCF Yield | 0.72% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
SHA:600131 has an Altman Z-Score of 4.11 and a Piotroski F-Score of 4.
| Altman Z-Score | 4.11 |
| Piotroski F-Score | 4 |